Taipei, Taiwan

Yu-Han Kao

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Yu-Han Kao

Introduction

Yu-Han Kao is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical formulations for treating autoimmune diseases. With a total of 4 patents to his name, his work continues to impact the medical community.

Latest Patents

One of Yu-Han Kao's latest patents involves a topical formulation comprising tofacitinib. This formulation includes a therapeutically effective amount of tofacitinib, at least one solvent, and optionally one or more other pharmaceutically acceptable excipients. The patent also outlines a method for treating and/or preventing autoimmune diseases in a subject by administering this topical formulation. This innovative approach showcases his commitment to advancing treatment options for patients.

Career Highlights

Throughout his career, Yu-Han Kao has worked with prominent companies such as Pegatron Corporation and Twi Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to various projects that enhance pharmaceutical formulations.

Collaborations

Yu-Han Kao has collaborated with several professionals in his field, including Kuang-Hsun Hsieh and Yu-Yang Chao. These collaborations have fostered a productive environment for innovation and development in pharmaceutical research.

Conclusion

In summary, Yu-Han Kao is a distinguished inventor whose work in topical formulations has the potential to transform the treatment of autoimmune diseases. His patents and collaborations reflect his dedication to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…